Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,020 | 2 | 50.9% |
| Food and Beverage | $1,472 | 58 | 24.8% |
| Travel and Lodging | $1,446 | 3 | 24.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $5,054 | 23 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $484.47 | 24 | $0 (2024) |
| Madrigal Pharmaceuticals | $153.87 | 2 | $0 (2024) |
| ABBVIE INC. | $123.03 | 7 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $58.36 | 3 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $38.38 | 2 | $0 (2024) |
| Echosens North America, Inc. | $26.04 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,435 | 31 | Gilead Sciences, Inc. ($4,930) |
| 2023 | $140.84 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($63.77) |
| 2022 | $191.83 | 13 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($137.78) |
| 2021 | $170.76 | 11 | Gilead Sciences, Inc. ($64.84) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $980.00 | General |
| Category: INFLAM | ||||||
| 11/22/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Rare Disease | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $94.42 | General |
| Category: INFLAM | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: LIVER DISEASE | ||||||
| 11/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $121.34 | General |
| Category: Gastroenterology | ||||||
| 10/28/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.14 | General |
| 10/09/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $74.52 | General |
| Category: INFLAM | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $46.21 | General |
| Category: INFLAM | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: INFLAM | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: INFLAM | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,040.00 | General |
| Category: INFLAM | ||||||
| 09/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: LIVER DISEASE | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Gastroenterology | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $742.95 | General |
| Category: INFLAM | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $449.50 | General |
| Category: INFLAM | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $253.49 | General |
| Category: INFLAM | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $59.36 | General |
| Category: INFLAM | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $55.55 | General |
| Category: INFLAM | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $52.20 | General |
| Category: INFLAM | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $36.84 | General |
| Category: INFLAM | ||||||
| 08/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Gastroenterology | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Gastroenterology | ||||||
| 04/23/2024 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $20.44 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 442 | 565 | $125,644 | $35,276 |
| 2022 | 6 | 459 | 575 | $126,277 | $37,785 |
| 2021 | 5 | 360 | 472 | $99,966 | $33,552 |
| 2020 | 7 | 292 | 359 | $87,766 | $24,956 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 334 | $80,983 | $23,250 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 28 | $9,502 | $2,930 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $8,695 | $2,619 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $11,331 | $2,546 | 22.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 32 | 39 | $6,699 | $1,874 | 28.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 22 | 24 | $5,843 | $1,623 | 27.8% |
| 91200 | Measurement of liver stiffness | Facility | 2023 | 86 | 86 | $2,591 | $434.20 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 253 | 360 | $87,838 | $26,015 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $13,588 | $4,040 | 29.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 44 | 48 | $11,712 | $3,568 | 30.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 17 | $5,831 | $1,948 | 33.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 28 | 31 | $5,332 | $1,728 | 32.4% |
| 91200 | Measurement of liver stiffness | Facility | 2022 | 75 | 76 | $1,976 | $486.74 | 24.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 239 | 346 | $78,888 | $26,458 | 33.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $11,427 | $3,863 | 33.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 23 | 27 | $3,826 | $1,470 | 38.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $4,257 | $1,451 | 34.1% |
| 91200 | Measuring the stiffness in the liver via elastography | Facility | 2021 | 48 | 49 | $1,568 | $310.89 | 19.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 132 | 174 | $36,018 | $10,111 | 28.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 27 | 27 | $13,122 | $3,536 | 27.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 47 | 53 | $10,971 | $3,506 | 32.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 29 | 48 | $12,000 | $3,182 | 26.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $7,488 | $2,152 | 28.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 14 | 14 | $5,488 | $1,602 | 29.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 19 | $2,679 | $867.18 | 32.4% |
About Blake Williams, ARNP
Blake Williams, ARNP is a Family healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1245624626.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Blake Williams, ARNP has received a total of $5,938 in payments from pharmaceutical and medical device companies, with $5,435 received in 2024. These payments were reported across 63 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,020).
As a Medicare-enrolled provider, Williams has provided services to 1,553 Medicare beneficiaries, totaling 1,971 services with total Medicare billing of $131,570. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Des Moines, IA
- Active Since 03/24/2015
- Last Updated 03/07/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1245624626
Products in Payments
- Livdelzi (Drug) $4,898
- XIFAXAN (Drug) $484.47
- RESMETIROM (Drug) $153.87
- MAVYRET (Drug) $123.03
- OCALIVA (Drug) $58.36
- FibroScan (Device) $26.04
- IQIRVO (Drug) $17.94
- Epclusa (Drug) $13.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Des Moines
Mrs. Jackie Shipley, Arnp, ARNP
Family — Payments: $6,672
Dr. Becky Johnson, Dnp, Arnp, Aahivs, DNP, ARNP, AAHIVS
Family — Payments: $5,713
Ms. Magdalena Dawson, Aprn, APRN
Family — Payments: $3,486
Mrs. Elaine Selden, Np-C, NP-C
Family — Payments: $3,074
Megan Bradley, Arnp, ARNP
Family — Payments: $2,494
Erica Jones
Family — Payments: $2,452